Defects in mesenchymal stem cell self-renewal and cell fate determination lead to an osteopenic phenotype in Bmi-1 null mice
Mice, Knockout
Polycomb Repressive Complex 1
0301 basic medicine
Reverse Transcriptase Polymerase Chain Reaction
Blotting, Western
Nuclear Proteins
Apoptosis
Cell Differentiation
Mesenchymal Stem Cells
Immunohistochemistry
Bone and Bones
Repressor Proteins
Bone Diseases, Metabolic
Mice
03 medical and health sciences
Phenotype
Proto-Oncogene Proteins
Animals
Cells, Cultured
DOI:
10.1359/jbmr.090812
Publication Date:
2009-08-04T15:29:27Z
AUTHORS (8)
ABSTRACT
Abstract
In parathyroid hormone–related protein 1-84 [PTHrP(1-84)] knockin mice, expression of the polycomb protein Bmi-1 is reduced and potentially can mediate the phenotypic alterations observed. We have therefore now examined the skeletal phenotype of Bmi-1−/− mice in vivo and also assessed the function of bone marrow mesenchymal stem cells (BM-MSCs) from Bmi-1−/− mice ex vivo in culture. Neonatal Bmi-1−/− mice exhibited skeletal growth retardation, with reduced chondrocyte proliferation and increased apoptosis. Osteoblast numbers; gene expression of alkaline phosphatase, type I collagen, and osteocalcin; the mineral apposition rate; trabecular bone volume; and bone mineral density all were reduced significantly; however, the number of bone marrow adipocytes and Ppar-γ expression were increased. These changes were consistent with the skeletal phenotype observed in the PTHrP(1-84) knockin mouse. The efficiency of colony-forming unit fibroblast (CFU-F) formation in bone marrow cultures was decreased, and the percentage of alkaline phosphatase–positive CFU-F and Runx2 expression were reduced. In contrast, adipocyte formation and Ppar-γ expression in cultures were increased, and expression of the polycomb protein sirtuin (Sirt1) was reduced. Reduced proliferation and increased apoptosis of BM-MSCs were associated with upregulation of senescence-associated tumor-suppressor genes, including p16, p19, and p27. Analysis of the skeletal phenotype in Bmi-1−/− mice suggests that Bmi-1 functions downstream of PTHrP. Furthermore, our studies indicate that Bmi-1 maintains self-renewal of BM-MSCs by inhibiting the expression of p27, p16, and p19 and alters the cell fate of BM-MSCs by enhancing osteoblast differentiation and inhibiting adipocyte differentiation at least in part by stimulating Sirt1 expression. Bmi-1 therefore plays a critical role in promoting osteogenesis. © 2010 American Society for Bone and Mineral Research
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (49)
CITATIONS (82)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....